scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1090906287 |
P356 | DOI | 10.1007/S10815-017-1001-8 |
P932 | PMC publication ID | 5699982 |
P698 | PubMed publication ID | 28748493 |
P2093 | author name string | Xiao Xu | |
Winifred Mak | |||
Stephen C Collins | |||
P2860 | cites work | Abortion Incidence and Access to Services In the United States, 2008 | Q22306085 |
Accuracy of preimplantation genetic screening (PGS) is compromised by degree of mosaicism of human embryos | Q28831313 | ||
Outcomes of in vitro fertilization with preimplantation genetic diagnosis: an analysis of the United States Assisted Reproductive Technology Surveillance Data, 2011-2012 | Q31020106 | ||
Willingness to pay for a quality-adjusted life year: in search of a standard | Q33993542 | ||
In vitro fertilization with preimplantation genetic screening improves implantation and live birth in women age 40 through 43. | Q35186895 | ||
Reduction of multiple pregnancies in the advanced maternal age population after implementation of an elective single embryo transfer policy coupled with enhanced embryo selection: pre- and post-intervention study | Q35974858 | ||
Selecting the optimal time to perform biopsy for preimplantation genetic testing | Q38133071 | ||
Diagnosis of human preimplantation embryo viability | Q38310795 | ||
Influence of race and ethnicity on in vitro fertilization outcomes: systematic review | Q38585522 | ||
Validation of next-generation sequencing for comprehensive chromosome screening of embryos | Q38823200 | ||
In vitro fertilization with preimplantation genetic diagnosis for aneuploidies in advanced maternal age: a randomized, controlled study | Q38825105 | ||
The why, the how and the when of PGS 2.0: current practices and expert opinions of fertility specialists, molecular biologists, and embryologists | Q38852215 | ||
Fresh versus frozen: initial transfer or cumulative cycle results: how do we interpret results and design studies? | Q38870669 | ||
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine | Q38953322 | ||
Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold | Q39268069 | ||
Comprehensive chromosome screening alters traditional morphology-based embryo selection: a prospective study of 100 consecutive cycles of planned fresh euploid blastocyst transfer | Q39409658 | ||
Mean Age of Mothers is on the Rise: United States, 2000-2014. | Q40039112 | ||
Optimal euploid embryo transfer strategy, fresh versus frozen, after preimplantation genetic screening with next generation sequencing: a randomized controlled trial. | Q41597588 | ||
Obstetrical and neonatal outcomes from the BEST Trial: single embryo transfer with aneuploidy screening improves outcomes after in vitro fertilization without compromising delivery rates | Q45710307 | ||
Preimplantation genetic screening in older women: a cost-effectiveness analysis. | Q46027773 | ||
Morphological and cytogenetic assessment of cleavage and blastocyst stage embryos | Q46790679 | ||
Cost-effectiveness analysis of preimplantation genetic screening and in vitro fertilization versus expectant management in patients with unexplained recurrent pregnancy loss | Q46922876 | ||
How do patient perceived determinants influence the decision-making process to accept or decline preimplantation genetic screening? | Q47371065 | ||
The willingness to pay for in vitro fertilization: a pilot study using contingent valuation | Q47561745 | ||
Effects of maternal age on euploidy rates in a large cohort of embryos analyzed with 24-chromosome single-nucleotide polymorphism-based preimplantation genetic screening | Q48557679 | ||
Cell-free fetal DNA screening in the USA: a cost analysis of screening strategies. | Q51042727 | ||
Female age-related fertility decline. Committee Opinion No. 589. | Q51158804 | ||
Embryo morphology, developmental rates, and maternal age are correlated with chromosome abnormalities. | Q52206925 | ||
Mosaicism: "survival of the fittest" versus "no embryo left behind". | Q53189736 | ||
In Vitro Fertilization with Preimplantation Genetic Screening | Q59782826 | ||
Healthy Babies after Intrauterine Transfer of Mosaic Aneuploid Blastocysts | Q60018989 | ||
Beyond usual care: the economic consequences of expanding treatment options in early pregnancy loss | Q85222629 | ||
Pregnancy outcomes decline with increasing body mass index: analysis of 239,127 fresh autologous in vitro fertilization cycles from the 2008-2010 Society for Assisted Reproductive Technology registry | Q86840639 | ||
Preimplantation genetic screening: who benefits? | Q89365141 | ||
P577 | publication date | 2017-07-27 | |
P1433 | published in | Journal of Assisted Reproduction and Genetics | Q15755113 |
P1476 | title | Cost-effectiveness of preimplantation genetic screening for women older than 37 undergoing in vitro fertilization |